Comprehensive Seminar on Regenerative Medicine Drug Production and GCTP Compliance

Comprehensive Overview of the Seminar

The IR Technical Education Institute is set to host a detailed seminar that explores the manufacturing of investigational drugs in the field of regenerative medicine. This event will cover everything from relevant laws and guidelines to the manufacturing processes adhering to Good Clinical Test Practices (GCTP), and handling potential setbacks.

Understanding Regenerative Medical Products

Regenerative medical products include innovative medical advancements that utilize cellular and genetic approaches. With ongoing research and development, the number of approved products is steadily increasing, thus offering new treatment options for previously challenging diseases. However, due to their biological nature, products based on cells often exhibit greater variability in quality compared to chemical counterparts. Consequently, regulatory frameworks are evolving, emphasizing the need to ensure safety, efficacy, and quality during drug production as per applicable laws and standards.

For professionals in the development and manufacturing of regenerative medical products, it is critical to grasp the distinctions from traditional chemical pharmaceuticals and be well-versed in the relevant guidelines that govern GCTP.

Seminar Details

- Event Title: Manufacturing of Investigational Drugs for Regenerative Medical Products: Approaches and Critical Points Under GCTP
- Location: Japan IR Headquarters Seminar Room, Akihabara, Tokyo
- Date and Time: December 18, 2026, from 10:00 AM to 4:00 PM
- Capacity: 16 participants
- Tuition Fee: 49,500 JPY (tax included) / participant (discount available for group registrations)
- Instructor: Wataru Kokubo, Representative of Fahn Consulting Office

Seminar Outline

The seminar will systematically cover essential aspects of regenerative medical products, including:

- Fundamentals of Regenerative Medical Products: Understanding basic concepts, differences with chemical drugs, and product characteristics.
- Laws and Guidelines Involved: Insights on Pharmaceutical and Medical Device Act, Safety Assurance Act, and the roles of PMDA (Pharmaceuticals and Medical Devices Agency).
- Manufacturing Processes and Considerations: Managing raw cells, ensuring sterile production, cell cultivation, sampling, freezing, storage, transport, and understanding investigational protocols.
- GCTP Principles: Best practices in risk management, manufacturing and quality control systems, documentation, equipment, education management, validation, deviation management, and quality assurance.

Target Audience

This seminar is ideally suited for:

- Pharmaceutical research staff involved in investigational drug manufacturing.
- Individuals overseeing management of investigational drug production.
- Those interested in learning the fundamentals of investigational drug production within regenerative medicine.

For more details, visit our website: Japan IR Seminar

The IR Technical Education Institute remains dedicated to providing practical knowledge and skills through various educational services, including seminars, e-learning, and training programs for manufacturing professionals. With over 50 years of experience, Japan IR Corporation offers specialized technical solutions and a wide array of services ranging from patent and intellectual property solutions to technical training and content creation.